TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/9/26 19:03 | 3/9/26 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 2 | 2 | P.m | 695 | 4.81 | 0 | 145 | 22 | 808 | D | ||||||||||||||
3/9/26 16:30 | 3/6/26 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 2 | 2 | P.d | 143 | 2.17 | 0 | 66 | 18 | 438 | D | ||||||||||||||
2/19/26 16:18 | 2/13/26 | QDEL | Quidelortho Corp | Health | Diagn | In Vitro & In Vivo Diagnostic | 3 | 4 | P | 648 | 23.74 | 0 | 27 | 16 | 199 | I | |||||||||||||||
2/17/26 15:12 | 2/17/26 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 3 | P.m | 2 | 9.65 | 0 | 0 | 42 | 1 | I | ||||||||||||||
2/12/26 19:49 | 2/10/26 | IMDX | Insight Molecular Diagnostics Inc. | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P.d | 3,000 | 5.75 | 0 | 522 | 2 | 23,864 | M | ||||||||||||||
1/7/26 16:05 | 1/5/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P | 1,403 | 9.35 | 0 | 150 | 261 | 207 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |